Autres langues Vicore Pharma Holding AB

Actions

VICO

SE0007577895

Marché Fermé - Nasdaq Stockholm Autres places de cotation 17:29:39 26/04/2024			Varia. 5j.	Varia. 1 janv.
17,3 ^SEK	+3,72%		+6,00%	+22,00%

04/04	Vicore Pharma Holding AB (Publ) annonce que Maarten Kraan, en tant que membre du conseil d'administration, a refusé d'être réélu	CI
19/03	Vicore annonce la désignation par la FDA d'un dispositif révolutionnaire pour AlmeeTM, une thérapie numérique pour les patients atteints de fibrose pulmonaire	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Vicore to Present at Upcoming April 2024 Investor Conferences	15/04
Vicore to Present at Upcoming Investor Conferences	15/04
Vicore to Present at Upcoming Investor Conferences	12/04
Vicore Pharma Holding AB Announces Maarten Kraan, as Board Member Declined Re-Election	04/04
Notice of annual general meeting of Vicore Pharma Holding AB (publ)	04/04
Vicore Announces Presentations at the 2024 American Thoracic Society International Conference	28/03
Vicore publishes the Annual Report for 2023	27/03
Vicore Announces FDA Breakthrough Device Designation for AlmeeTM, a Digital Therapy for Patients with Pulmonary Fibrosis	19/03
Vicore Announces FDA Breakthrough Device Designation for AlmeeTM, a Digital Therapy for Patients with Pulmonary Fibrosis	19/03
Year-end report 2023	28/02
Vicore Pharma Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28/02
Vicore Pharma Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Vicore to Present at Upcoming Investor Conferences	27/02
Vicore Pharma Signs Licensing Deal for Idiopathic Pulmonary Fibrosis Drug Candidate	09/02
Vicore and Nippon Shinyaku Enter into an Exclusive License Agreement to Develop and Commercialize C21 in Japan	09/02
Vicore to Present at Upcoming Investor Conferences	31/01
Alex Therapeutics and Vicore Pharma Announces Positive Results of the COMPANION Study	04/01
Alex Therapeutics Reports Positive Results from the Randomized-Controlled Trial of its Digital Therapy for Anxiety	04/01
Vicore Reports Positive Results for the Pivotal Study of its Digital Therapy for Patients with Pulmonary Fibrosis	04/01
Vicore Pharma Holding AB Confirms IPF Development Program on Track and Provides Early-Stage Pipeline Updates	02/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Vicore Pharma Holding AB

Actions

VICO

SE0007577895

Autres langues

Filtres